Federated Hermes, Inc. Neogenomics Inc Transaction History

Federated Hermes, Inc.

$50.2 Billion
Q2 2025

A detailed history of Federated Hermes, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 161,683 shares of NEO stock, worth $1.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

161,683

Previous 161,428 0.16%

Holding current value

$1.48 Million

Previous $1.53 Million 22.86%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$6.4 - $10.27 $1,632 - $2,618	255 Added 0.16%	161,683 $1.18 Million
Q1 2025 May 08, 2025	BUY	$9.09 - $18.61 $144,412 - $295,657	15,887 Added 10.92%	161,428 $1.53 Million
Q4 2024 Feb 13, 2025	BUY	$13.0 - $18.43 $79,118 - $112,164	6,086 Added 4.36%	145,541 $2.4 Million
Q3 2024 Nov 13, 2024	SELL	$13.4 - $17.73 $41,968 - $55,530	-3,132 Reduced 2.2%	139,455 $2.06 Million
Q2 2024 Aug 08, 2024	BUY	$13.01 - $15.77 $150,902 - $182,916	11,599 Added 8.86%	142,587 $1.98 Million
Q1 2024 May 14, 2024	SELL	$14.06 - $16.79 $259,449 - $309,825	-18,453 Reduced 12.35%	130,988 $2.06 Million
Q4 2023 Jan 31, 2024	SELL	$11.67 - $20.73 $1.87 Million - $3.33 Million	-160,647 Reduced 51.81%	149,441 $2.42 Million
Q3 2023 Nov 13, 2023	SELL	$12.15 - $17.85 $876,671 - $1.29 Million	-72,154 Reduced 18.88%	310,088 $3.81 Million
Q2 2023 Aug 14, 2023	SELL	$14.1 - $19.83 $3.33 Million - $4.68 Million	-235,901 Reduced 38.16%	382,242 $6.14 Million
Q1 2023 May 08, 2023	SELL	$9.09 - $19.45 $7.19 Million - $15.4 Million	-790,479 Reduced 56.12%	618,143 $10.8 Million
Q4 2022 Feb 13, 2023	SELL	$6.45 - $12.07 $4.29 Million - $8.02 Million	-664,792 Reduced 32.06%	1,408,622 $13 Million
Q3 2022 Nov 14, 2022	SELL	$7.86 - $12.91 $4.74 Million - $7.78 Million	-602,622 Reduced 22.52%	2,073,414 $17.9 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $13.97 $14 Million - $27.7 Million	1,986,369 Added 288.02%	2,676,036 $21.8 Million
Q1 2022 May 13, 2022	SELL	$12.15 - $35.28 $12.8 Million - $37.3 Million	-1,056,455 Reduced 60.5%	689,667 $8.38 Million
Q3 2021 Nov 15, 2021	BUY	$41.66 - $52.52 $25.9 Million - $32.7 Million	622,222 Added 55.36%	1,746,122 $84.2 Million
Q2 2021 Aug 16, 2021	SELL	$36.62 - $51.69 $585 - $827	-16 Reduced -0.0%	1,123,900 $50.8 Million
Q1 2021 May 13, 2021	BUY	$41.56 - $59.88 $4.11 Million - $5.92 Million	98,825 Added 9.64%	1,123,916 $54.2 Million
Q4 2020 Feb 12, 2021	SELL	$36.08 - $56.47 $26,771 - $41,900	-742 Reduced 0.07%	1,025,091 $55.2 Million
Q3 2020 Nov 12, 2020	SELL	$33.26 - $40.48 $11,441 - $13,925	-344 Reduced 0.03%	1,025,833 $37.8 Million
Q2 2020 Aug 13, 2020	SELL	$24.21 - $31.02 $3.07 Million - $3.93 Million	-126,837 Reduced 11.0%	1,026,177 $31.8 Million
Q1 2020 May 13, 2020	BUY	$20.5 - $34.53 $6.68 Million - $11.3 Million	325,881 Added 39.4%	1,153,014 $31.8 Million
Q4 2019 Feb 14, 2020	SELL	$18.96 - $29.84 $3.38 Million - $5.32 Million	-178,420 Reduced 17.74%	827,133 $24.2 Million
Q3 2019 Nov 14, 2019	SELL	$19.12 - $26.24 $11.7 Million - $16.1 Million	-612,273 Reduced 37.85%	1,005,553 $19.2 Million
Q2 2019 Aug 14, 2019	BUY	$19.57 - $24.1 $18.1 Million - $22.2 Million	922,362 Added 132.63%	1,617,826 $35.5 Million
Q1 2019 May 10, 2019	SELL	$12.14 - $20.46 $744,145 - $1.25 Million	-61,297 Reduced 8.1%	695,464 $14.2 Million
Q4 2018 Feb 13, 2019	SELL	$11.24 - $18.5 $956,771 - $1.57 Million	-85,122 Reduced 10.11%	756,761 $9.54 Million
Q3 2018 Nov 13, 2018	BUY	$12.5 - $15.38 $2.79 Million - $3.43 Million	222,983 Added 36.03%	841,883 $12.9 Million
Q2 2018 Aug 10, 2018	BUY	$7.99 - $14.05 $572,084 - $1.01 Million	71,600 Added 13.08%	618,900 $8.11 Million
Q3 2017 Nov 13, 2017	BUY	$9.11 - $11.26 $4.99 Million - $6.16 Million	547,300	547,300 $6.09 Million

Others Institutions Holding NEO

# of Institutions

307

Shares Held

129M

Call Options Held

1.17M

Put Options Held

297K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.15B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Neogenomics Inc Transaction History